Novartis AG (SWX:NOVN)
113.56
-1.16 (-1.01%)
Apr 29, 2026, 12:20 PM CET
Novartis AG Revenue
Novartis AG had revenue of $13.52B USD in the quarter ending March 31, 2026, a decrease of -0.70%. This brings the company's revenue in the last twelve months to $56.58B, up 6.31% year-over-year. In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth.
Revenue (ttm)
$56.58B
Revenue Growth
+6.31%
P/S Ratio
4.82
Revenue / Employee
$751.70K
Employees
75,267
Market Cap
218.90B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.67B | 4.95B | 9.57% |
| Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
| Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
| Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
| Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Alcon | 8.25B |
| Sandoz Group AG | 8.85B |
| Straumann Holding AG | 2.61B |
| Sonova Holding AG | 3.85B |
| Galenica AG | 4.15B |
Novartis AG News
- 1 hour ago - UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies - CNBC
- 20 hours ago - Novartis Stock Declines After Q1 Revenue Misses Expectations - GuruFocus
- 20 hours ago - Market Update: Microsoft (MSFT), Novartis (NVS), Coca-Cola (KO) Performance Amidst Economic Concerns - GuruFocus
- 21 hours ago - Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales - Investor's Business Daily
- 22 hours ago - Novartis AG Earnings Call Transcript: Q1 2026 - Transcripts
- 23 hours ago - Novartis (NVS) Reports Q1 Sales and Pipeline Progress - GuruFocus
- 23 hours ago - Novartis (NVS) Reports Disappointing Q1 2026 Results Amid Generic Competition - GuruFocus
- 1 day ago - Novartis CEO Warns of Drug Pricing Policy Impact on Pharma Sector - GuruFocus